159 related articles for article (PubMed ID: 27459746)
1. [Long-Term Efficacy of BCNU Wafers for Malignant Gliomas].
Arakawa Y
Gan To Kagaku Ryoho; 2016 Jun; 43(6):690-3. PubMed ID: 27459746
[No Abstract] [Full Text] [Related]
2. The role of BCNU polymer wafers (Gliadel) in the treatment of malignant glioma.
Nagpal S
Neurosurg Clin N Am; 2012 Apr; 23(2):289-95, ix. PubMed ID: 22440872
[TBL] [Abstract][Full Text] [Related]
3. [Risk Factors for Adverse Events after Implantation of BCNU Wafers in High-grade Gliomas].
Yoshida M; Yamaguchi S; Ishi Y; Endo S; Motegi H; Kobayashi H; Asaoka K; Kamoshima Y; Terasaka S; Houkin K
No Shinkei Geka; 2015 Jul; 43(7):603-10. PubMed ID: 26136324
[TBL] [Abstract][Full Text] [Related]
4. Combination of intracranial temozolomide with intracranial carmustine improves survival when compared with either treatment alone in a rodent glioma model.
Recinos VR; Tyler BM; Bekelis K; Sunshine SB; Vellimana A; Li KW; Brem H
Neurosurgery; 2010 Mar; 66(3):530-7; discussion 537. PubMed ID: 20173548
[TBL] [Abstract][Full Text] [Related]
5. Risk management in the treatment of malignant gliomas with BCNU wafer implants.
Giese A; Bock HC; Kantelhardt SR; Rohde V
Cent Eur Neurosurg; 2010 Nov; 71(4):199-206. PubMed ID: 20063259
[TBL] [Abstract][Full Text] [Related]
6. Carmustine wafer implantation when surgical cavity is communicating with cerebral ventricles: technical considerations on a clinical series.
Della Puppa A; Rossetto M; Ciccarino P; Denaro L; Rotilio A; d'Avella D; Scienza R
World Neurosurg; 2011; 76(1-2):156-9; discussion 67-8. PubMed ID: 21839967
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors and survival in a prospective cohort of patients with high-grade glioma treated with carmustine wafers or temozolomide on an intention-to-treat basis.
Catalán-Uribarrena G; Bilbao-Barandica G; Pomposo-Gaztelu I; Undabeitia-Huertas J; Ruiz de Gopegui-Ruiz E; Galbarriatu-Gutiérrez L; Canales-Llantada M; Aurrecoechea-Obieta J; Igartua-Azkune A; Carbayo-Lozano G
Acta Neurochir (Wien); 2012 Feb; 154(2):211-22; discussion 222. PubMed ID: 22002506
[TBL] [Abstract][Full Text] [Related]
8. Malignant glioma: who benefits from adjuvant chemotherapy?
DeAngelis LM; Burger PC; Green SB; Cairncross JG
Ann Neurol; 1998 Oct; 44(4):691-5. PubMed ID: 9778271
[TBL] [Abstract][Full Text] [Related]
9. [Local chemotherapy for brain tumors].
Med Monatsschr Pharm; 2006 Dec; 29(12):460-1. PubMed ID: 17220043
[No Abstract] [Full Text] [Related]
10. Advancing the treatment of malignant glioma: act local, think global.
Abrey LE
Cancer Invest; 2004; 22(1):169. PubMed ID: 15069776
[No Abstract] [Full Text] [Related]
11. Incorporating BCNU wafers into malignant glioma treatment: European case studies.
Balossier A; Dörner L; Emery E; Heese O; Mehdorn HM; Menei P; Singh J
Clin Drug Investig; 2010; 30(3):195-204. PubMed ID: 20155992
[TBL] [Abstract][Full Text] [Related]
12. The role of interstitial BCNU chemotherapy in the treatment of malignant glioma.
Engelhard HH
Surg Neurol; 2000 May; 53(5):458-64. PubMed ID: 10874145
[TBL] [Abstract][Full Text] [Related]
13. Carmustine wafers: localized delivery of chemotherapeutic agents in CNS malignancies.
Lin SH; Kleinberg LR
Expert Rev Anticancer Ther; 2008 Mar; 8(3):343-59. PubMed ID: 18366283
[TBL] [Abstract][Full Text] [Related]
14. Safety evaluation of high-dose BCNU-loaded biodegradable implants in Chinese patients with recurrent malignant gliomas.
Sai K; Zhong MG; Wang J; Chen YS; Mou YG; Ke C; Zhang XH; Yang QY; Lin FH; Guo CC; Chen ZH; Zeng J; Lv YC; Li X; Gao WC; Chen ZP
J Neurol Sci; 2014 Aug; 343(1-2):60-5. PubMed ID: 24874252
[TBL] [Abstract][Full Text] [Related]
15. [Treatment for malignant glioma].
Shibui S
No To Shinkei; 2005 Dec; 57(12):1027-33. PubMed ID: 16375187
[No Abstract] [Full Text] [Related]
16. Bax expressed from a herpes viral vector enhances the efficacy of N,N'-bis(2-hydroxyethyl)-N-nitrosourea treatment in a rat glioma model.
Lee A; DeJong G; Guo J; Bu X; Jia WW
Cancer Gene Ther; 2000 Aug; 7(8):1113-9. PubMed ID: 10975671
[TBL] [Abstract][Full Text] [Related]
17. Localized BCNU chemotherapy and the multimodal management of malignant glioma.
La Rocca RV; Mehdorn HM
Curr Med Res Opin; 2009 Jan; 25(1):149-60. PubMed ID: 19210148
[TBL] [Abstract][Full Text] [Related]
18. [Chemotherapy for gliomas in children].
Sawamura Y
Nihon Rinsho; 2005 Sep; 63 Suppl 9():478-82. PubMed ID: 16201567
[No Abstract] [Full Text] [Related]
19. Symptomatic Remote Cyst after BCNU Wafer Implantation for Malignant Glioma.
Matsumura H; Ishikawa E; Matsuda M; Sakamoto N; Akutsu H; Takano S; Matsumura A
Neurol Med Chir (Tokyo); 2018 Jun; 58(6):270-276. PubMed ID: 29780071
[TBL] [Abstract][Full Text] [Related]
20. [Intraoperative BCNU Wafer Implantation for High-Grade Glioma--A Questionnaire Targeting Japanese Neurosurgeons].
Ishikawa E; Yamamoto T
Gan To Kagaku Ryoho; 2016 May; 43(5):603-7. PubMed ID: 27210091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
